搜索临床试验以:抗PD-1抗体camrelizumab
总计6968个结果
-
Hangzhou Hanx Biopharmaceuticals, Ltd.Wuhan Hanxiong Bioscience, Ltd.主动,不招人
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Sixth Affiliated Hospital, Sun Yat-sen University招聘中
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical University主动,不招人
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest Medical University尚未招聘
-
Symphogen A/S完全的
-
Shandong New Time Pharmaceutical Co., LTD未知
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Agenus Inc.招聘中
-
Peking University First HospitalYiZhou International Cancer Hospital未知肿瘤转移 | 免疫疗法 | 质子治疗
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
Jason J. Luke, MD招聘中黑色素瘤 | 宫颈癌 | 肝细胞癌 | 胃癌 | 大肠癌 | 非小细胞肺癌 | 晚期实体瘤 | 胆管癌 | 膀胱癌 | 肾癌 | 肛门癌 | 默克尔细胞癌 | HNSCC美国
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国